Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine effects on adaptation to environmental change in healthy adults
NL-OMON38317Active, not recruiting
- Sponsor
- Vrije Universiteit Amsterdam
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Double-blind trial of atomoxetine (2 arms), sponsored by Vrije Universiteit Amsterdam. Primary endpoints: von Restorff effect, Novelty preference and 2 more. Started Oct 2012; status: active, not recruiting.
02
Drugs
atomoxetine
Beyond the preview
Go deeper on NL-OMON38317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38317.